| |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Rivascolarizzazione coronarica: meglio angioplastica o by-pass?
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Fibromialgia: alcune novità sulla terapia
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
La gravita’ della colpa va rapportata alle difficolta’ dell’ intervento
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Utilita' dello screening cardiovascolare: risultati dello studio DANCAVAS
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
E’ la dose che fa il veleno. E l’alcol?
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Dispositivi Digitali Pre-Diagnostici Indossabili: i problemi
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
La terapia ipoglicemizzante nel diabete tipo 2 - Parte seconda
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Neoplasia: implicazioni psicologiche personali e familiari
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
LA VISITA IN OSPEDALE - Cap. 2 e 3
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Terapia ipoglicemizzante nel diabete tipo 2 - Parte prima
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
Pagina precedente Pagina successiva
| |
|